C
PRME icon

Covestor’s Prime Medicine PRME Stock Holding History

Covestor’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
31
– – ﹤0.01% 2671
2025
Q4 		$0 Hold
31
– – ﹤0.01% 2642
2025
Q3 		$0 Hold
31
– – ﹤0.01% 2660
2025
Q2 		$0 Sell
31
-2
-6% -$3 ﹤0.01% 2638
2025
Q1 		$0 Buy
33
+19
+136% +$48 ﹤0.01% 2618
2024
Q4 		$0 Buy
14
+1
+8% +$4 ﹤0.01% 2626
2024
Q3 		$0 Sell
13
-1
-7% -$5 ﹤0.01% 2635
2024
Q2 		$0 Hold
14
– – ﹤0.01% 2638
2024
Q1 		$0 Sell
14
-1
-7% -$8 ﹤0.01% 2625
2023
Q4 		$0 Buy
15
+7
+88% +$54 ﹤0.01% 2583
2023
Q3 		$0 Sell
8
-1
-11% -$13 ﹤0.01% 2576
2023
Q2 		$0 Hold
9
– – ﹤0.01% 2527
2023
Q1 		$0 Buy
+9
New +$147 ﹤0.01% 2453

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Covestor's PRME Position: Q1 2026 in Review

Covestor held its Prime Medicine (PRME) position steady in Q1 2026 at 31 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

Covestor first reported a position in PRME in Q1 2023 and has held it in 13 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Covestor held 31 shares of Prime Medicine worth $0 as of Q1 2026.
  • Covestor left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2671 holding.
  • Covestor first reported a position in Prime Medicine in Q1 2023 and has held it in 13 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.